Posted in Clinical Data Spyre drug for inflammatory bowel disease shows promise in early study April 13, 2026 BioPharma Dive The therapy, which works similarly to Takeda s blockbuster Entyvio, showed remission rates that suggest a best-in-class profile, the company said. Clinical DataImmunology & InflammationRead full story